Transaction #18445 · Form 4 · 0001193125-25-316344
LEMAITRE VASCULAR INC · Stock award · Stock Option (Right to Buy)
LEMAITRE VASCULAR INC · Transacted December 10, 2025 · Filed December 11, 2025
What does this filing report?
An SEC Form 4 filing for LEMAITRE VASCULAR INC records a stock award involving Stock Option (Right to Buy) on December 10, 2025. The reported quantity was 3,431. The filing date is December 11, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- LEMAITRE VASCULAR INC
- Company CIK
- 0001158895
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 3,431
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 3,431
- Ownership description
- Not reported
- SEC acceptance time
- Dec 11, 2025, 6:08 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- O'Connor John James ↗
Director
CIK 0001382475
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 3,431
- Conversion / exercise price
- 83.66
- Exercise date
- December 1, 2025
- Expiration date
- December 10, 2030
Filing footnotes & remarks
- F1
- Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.
- F2
- This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.